Received:08 September 2016,
Published:28 February 2017
移动端阅览
Lingxi Kong, Yan Huang, Feng Qiu, et al. Effect of Honghua Injection on distribution of levofloxacin in uterine tissue of pelvic inflammatory rats[J]. J Third Mil Med Univ, 2017, 39(4): 361-366.
Lingxi Kong, Yan Huang, Feng Qiu, et al. Effect of Honghua Injection on distribution of levofloxacin in uterine tissue of pelvic inflammatory rats[J]. J Third Mil Med Univ, 2017, 39(4): 361-366. DOI: 10.16016/j.1000-5404.201609061.
Objective
2
To study the effect of Honghua Injection on the distribution of levofloxacin (LVFX) in the uterine tissue of pelvic inflammatory rat model.
Method
2
Ninety-six female rats with bacterial pelvic inflammation
were randomly divided into (
n
=48 per group) experimental group (combined treatment of Honghua and LVFX) and control group (only LVFX). Rats in experimental group were intramuscularly injected with Honghua Injection (0.8 mL/kg) for 3 consecutive days
and those in the control group were given the same volume of normal saline. On the day 4
all the rats were orally administered with LVFX(80 mg/kg). Six rats of each group were sacrificed at each time point of 0.25
0.5
1
1.5
2
4
8 and 12 h after Honghua Injection for collecting the plasma and uterine samples. Concentrations of LVFX in the plasma and uterine homogenous tissues were detected by high performance liquid chromatography (HPLC)
and pharmacokinetic parameters were calculated with DAS 2 software.
Results
2
Concentration-time curves of LVFX of the both groups fit the two-compartment model. The values of main pharmacokinetic parameters in plasma and uterine tissue of experiment and control groups were listed as follows:
C
max
were 14.28±0.84 and 14.45±1.93 μg/mL for plasma
15.85±1.32 and 12.65±1.01 μg/mL for uterine;
t
max
were 1.42±0.20 and 1.50±0.01 h for plasma
1.25±0.27 and 1.17±0.26 h for uterine;
t
1/2β
were 7.69±2.61 and 7.32±2.80 h for plasma
7.95±5.29 and 9.16±3.00 h for uterine;Clearance (CL) were 1.25±0.18 and 1.35±0.25 L/(kg·h) for plasma
1.08±0.08 and 1.47±0.16 L/(kg·h) for uterine;Area under curve (AUC)
0?
t
were 55.13±5.42 and 51.73±5.27 μg·h/mL for plasma
63.69±3.95 and 48.95±4.11 μg·h/mL for uterine. Moreover
the differences of parameters
C
max
CL and AUC
0?
t
in the uterine tissue were statistically significant between the 2 groups (
P
<
0.01).
Conclusion
2
Honghua Injection can obviously increase the concentration of LVFX in the uterine tissue of pelvic inflammatory rats.
Soper D E Pelvic inflamma tor ydisease Obstet Gynecol 2010 116 2Pt1 419 428 10.1097/AOG.0b013e3181e92c54 Soper D E. Pelvic inflamma tor ydisease[J]. Obstet Gynecol, 2010, 116(2Pt1): 419-428.DOI: 10.1097/AOG.0b013e3181e92c54
杨 秀英 盆腔炎致病因素100例分析 中外医疗 2009 5 20 2 3 10.16662/j.cnki.1674-0742.2009.20.104 杨秀英. 盆腔炎致病因素100例分析[J].中外医疗, 2009, 5(20): 2-3. DOI: 10.16662/j.cnki.1674-0742.2009.20.104
黄 晓芳 彭 跃辉 宋 亚辉 盐酸左氧氟沙星用于妇科盆腔炎的疗效 中外医学研究 2013 11 4 24 25 http://www.cnki.com.cn/Article/CJFDTOTAL-YJZY201304019.htm 黄晓芳, 彭跃辉, 宋亚辉.盐酸左氧氟沙星用于妇科盆腔炎的疗效[J].中外医学研究, 2013, 11(4): 24-25.
于 辉 盐酸左氧氟沙星治疗妇科盆腔炎的临床效果及安全性分析 世界最新医学信息文摘 2014 14 12 148 10.3969/j.issn.1671-3141.2014.12.111 于辉.盐酸左氧氟沙星治疗妇科盆腔炎的临床效果及安全性分析[J].世界最新医学信息文摘, 2014, 14(12): 148, 155. DOI: 10.3969/j.issn.1671-3141.2014.12.111
韦 校 慢性盆腔炎的治疗进展 医学信息 2013 26 4 644 韦校.慢性盆腔炎的治疗进展[J]. 医学信息, 2013, 26(4): 644.
冉 娅 抗生素联合丹莪妇康煎膏?红花注射液治疗慢性盆腔炎的临床疗效观察 北方药学 2014 11 7 58 http://www.cnki.com.cn/Article/CJFDTOTAL-BFYX201407057.htm 冉娅.抗生素联合丹莪妇康煎膏、红花注射液治疗慢性盆腔炎的临床疗效观察[J]. 北方药学, 2014, 11(7): 58, 75.
廖 文平 药物治疗慢性盆腔炎临床分析 中国医药导刊 2013 15 8 1409 1410 http://www.cnki.com.cn/Article/CJFDTOTAL-DKYY201308072.htm 廖文平. 药物治疗慢性盆腔炎临床分析[J]. 中国医药导刊, 2013, 15(8): 1409-1410.
张 三元 闻 莉 大肠杆菌所致大鼠慢性盆腔炎动物模型的建立 医学研究通讯 2001 30 2 11 14 http://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ200102002.htm 张三元, 闻莉.大肠杆菌所致大鼠慢性盆腔炎动物模型的建立[J]. 医学研究通讯, 2001, 30(2): 11-14.
孔 令希 李 秀英 杨 辉 氨溴索对左氧氟沙星在大鼠血浆?肺组织和支气管液中分布的影响 中国新药与临床杂志 2013 32 10 789 793 http://www.cnki.com.cn/Article/CJFDTOTAL-XYYL201310006.htm 孔令希, 李秀英, 杨辉, 等.氨溴索对左氧氟沙星在大鼠血浆、肺组织和支气管液中分布的影响[J]. 中国新药与临床杂志, 2013, 32(10): 789-793.
秦 国东 肖 明朝 周 远大 坦索罗辛对大鼠细菌性前列腺炎组织中左氧氟沙星药动学的影响 中国抗生素杂志 2013 38 1 78 82 10.13461/j.cnki.cja.005128 秦国东, 肖明朝, 周远大, 等. 坦索罗辛对大鼠细菌性前列腺炎组织中左氧氟沙星药动学的影响[J]. 中国抗生素杂志, 2013, 38(1): 78-82. DOI: 10.13461/j.cnki.cja.005128
张 敏 刘 晓君 罗 成 痰热清注射液对左氧氟沙星在小鼠肺组织分布的影响 重庆医学 2015 44 15 2028 2030 10.3969/j.issn.1671-8348.2015.15.004 张敏, 刘晓君, 罗成, 等. 痰热清注射液对左氧氟沙星在小鼠肺组织分布的影响[J]. 重庆医学, 2015, 44(15): 2028-2030. DOI: 10.3969 / j .issn.1671 -8348.2015.15.004
罗 成 孔 令希 何 海霞 痰热清注射液对左氧氟沙星在大鼠血液和肺组织中分布的影响 中国抗生素杂志 2014 39 4 S3 S8 10.13461/j.cnki.cja.005338 罗成, 孔令希, 何海霞, 等. 痰热清注射液对左氧氟沙星在大鼠血液和肺组织中分布的影响[J]. 中国抗生素杂志, 2014, 39(4): S3-S8.DOI: 10.13461/j.cnki.cja.005338
Workowski K A Berman S M Introduction: Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines Clinical Infectious Diseases 2007 44 Suppl 3 S73 S76 10.1086/511430 Workowski K A, Berman S M. Introduction: Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines[J]. Clinical Infectious Diseases, 2007, 44(Suppl 3): S73-S76.DOI: 10.1086/511430
黄 华民 盐酸左氧氟沙星在盆腔炎治疗中的临床疗效及安全性评估 中国妇幼保健 2012 27 7 989 990 http://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201207013.htm 黄华民. 盐酸左氧氟沙星在盆腔炎治疗中的临床疗效及安全性评估[J]. 中国妇幼保健, 2012, 27(7): 989-990.
易 善勇 官 丽莉 杨 晶 红花药理作用及其开发与应用研究进展 北方园艺 2015 5 191 195 10.11937/bfyy.201505056 易善勇, 官丽莉, 杨晶, 等. 红花药理作用及其开发与应用研究进展[J]. 北方园艺, 2015(5): 191-195. DOI: 10.11937/bfyy.201505056
陈 淑涛 毛 盛伟 林 青 红花注射液在妇科疾病中的运用举隅 四川中医 2014 32 9 140 141 http://www.cnki.com.cn/Article/CJFDTOTAL-SCZY201409069.htm 陈淑涛, 毛盛伟, 林青, 等. 红花注射液在妇科疾病中的运用举隅[J]. 四川中医, 2014, 32(9) : 140-141.
万 先惠 秦 亚利 颜 涛 红花注射液药理作用研究进展 中医药学报 2011 39 6 109 110 http://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB201106045.htm 万先惠, 秦亚利, 颜涛. 红花注射液药理作用研究进展[J]. 中医药学报, 2011, 39(6): 109-110.
程 力 曾 莉 熊 薇 红花在妇科疾病中的应用体会 贵阳中医学院学报 2011 33 1 65 66 10.3969/j.issn.1002-1108.2011.01-37 程力, 曾莉, 熊薇, 等. 红花在妇科疾病中的应用体会[J]. 贵阳中医学院学报, 2011, 33(1): 65-66.DOI: 10.3969/j.issn.1002-1108.2011.01-37
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
